Calamos Advisors »

Halozyme Therapeutics shares owned by Calamos Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2010-12-31 $238k 30k 7.93

More positions owned by Calamos Advisors

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Western Digital Corp Note 3.000%11/1 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Calamos Advisors

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics